3M DDS Announces Collaboration With Presspart Group

ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with Presspart Group (a division of the German based Heitkamp & Thumann Group), a specialist medical device and pharmaceutical component manufacturer, whereby Presspart is now licensed to sell the 3M™ Dose by Dose Counter and Dose Indicator, adding to its expanding portfolio of capabilities with metered dose inhaler (MDI) actuators.

This agreement offers both organizations the opportunity to accelerate growth of dose counter technology in existing and future MDI development opportunities, with now expanded access to a variety of actuator configurations. 3M Drug Delivery Systems will continue to fully support current customers and offer the Dose by Dose Counter and Dose Indicator to future customers as part of its end-to-end inhalation technology expertise. Both technologies are compatible with most valves, and customizable to meet partners’ requirements. They are easy for patients to use and retain a familiar actuator look and feel.

“We place priority on meeting the needs of our customers through quality and performance,” said Peter Schmelzer, Chairman of the Managing Board, Presspart. “The Dose by Dose Counter is compatible with a wide range of MDIs and will help differentiate our products and remove guesswork for patients in the long-run.”

Presspart is known as a market leader in bespoke injection moulded components, namely MDI actuators, making this agreement with 3M an ideal match for both companies. With more than 40 years of success, Presspart is pleased to offer its customers the unique Dose by Dose Counter technology.

“We are excited to partner with a company that possesses the expertise, resources and industry knowledge Presspart has to offer,” said Cindy Kent, President & General Manager, 3M Drug Delivery Systems. “They understand the importance of details beyond the medication itself, focusing on the reliability of delivery systems.”

The 3M Dose Counter technology was the first integrated dose counter available for third party developments that was approved by the FDA in conjunction with an MDI product. It notifies patients of exactly how many doses of medication they have left in their MDI and helps prevent them from running out unexpectedly, thus protecting them from an unsafe situation. It also has the potential to minimize wastage of medication, which may have a positive effect on healthcare costs. Its clear display is easy to understand for a wide range of users, young and old, giving an incremental indication of doses remaining in the MDI. For more information, visit www.3M.com/dds.

About Presspart Group

Presspart offers pharmaceutical customers high-precision injection moulded plastic components and deep-drawn metal cans for respiratory drug delivery systems, with more than 40 years’ experience and a worldwide reputation for competence, quality and innovation in pharmaceutical and industrial sectors. Presspart’s Inhalation Product Technology Centre (IPTC) supports new product developments and strategic initiatives with our customers. Founded in 1970 and acquired by the Heitkamp and Thumann group in 2002, Presspart has 3 European manufacturing sites with Sales offices in China and the USA. For more information, please visit www.presspart.com.

About Heitkamp & Thumann Group

The Heitkamp & Thumann Group is a leading global partner for the supply of world class precision formed components in both metal and plastic. Founded in 1978, the Group today comprises more than twenty medium-sized companies located in 10 different countries. Efficiency, quality and innovation have always been at the very center of our corporate philosophy and entrepreneurial activities. Highly-qualified and motivated employees and lean structures make us successful all over the world. For more information, please visit www.HT-Group.com.

About 3M Drug Delivery Systems

3M Drug Delivery Systems partners with pharmaceutical and biotech companies to develop and manufacture pharmaceutical products using 3M’s inhalation, transdermal or microneedle drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities to help bring products to market. Regulatory expertise, quality assurance, operations, marketed product support and other in-house resources are available for each step of the development and commercialization process. For more information, please visitwww.3M.com/dds or call 1-800-643-8086.

About 3M

3M captures the spark of new ideas and transforms them into thousands of ingenious products. Our culture of creative collaboration inspires a never-ending stream of powerful technologies that make life better. 3M is the innovation company that never stops inventing. With $31 billion in sales, 3M employs 89,000 people worldwide and has operations in more than 70 countries. For more information, visit www.3M.com or follow @3MNews on Twitter.

3M is a trademark of 3M Company.

3M Contacts:
Sara Mahan
Karwoski & Courage
(612) 342-9701
s.mahan@creativepr.com

3M Drug Delivery Systems
3M Center, Bldg 275-3E-10
St. Paul, MN 55144